All In Biotech

Drug Trial Radar · NCT00209456

Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia

GEHC Has Decided Not to Provide This Detail But Will Rely on the Brief Title

Last checked: Nov 20, 2026Latest source record: May 16, 2007 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

326

Actual

Start

Nov 2003

Primary completion

Not stated

Sponsor

Lead sponsor
GE HealthcareIndustry
Sponsor type
Industry
First posted
Sep 21, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 55 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is designed to determine the diagnostic efficacy of the visual assessment of SPECT scans in differentiating between probable dementia with Lewy Bodies (DLB) and non-DLB dementia subjects determined by the clinical diagnosis of an independent expert consensus panel used as the standard of truth.

Conditions

  • Lewy Body Dementia
  • Non-DLB Dementia
  • Alzheimer's
  • Vascular Dementia

Interventions

  • DatSCANDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Sensitivity and specificity of DaTSCAN SPECT scans in differentiating between probable dementia with Lewy Bodies (DLB) and non-DLB dementia subjects.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Amersham Buchler GmbH Co. KG

    Ismaning, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.